Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guidelines on laboratories' percutaneous transluminal coronary angioplasty (PTCA) volumes too low?

This article was originally published in Clinica

Executive Summary

A new study confirms that cardiac catheterisation laboratories with higher volumes of percutaneous transluminal coronary angioplasty (PTCA) procedures have lower complication rates. However, Dr Stephen Kimmel and colleagues from University of Pennsylvania hospital report in JAMA (October 11th) that current guidelines of minimum volume to maintain competence may be too low. Data from 19,594 PTCA patients in 48 cardiac catheterisation centres in the US and Canada showed that increasing laboratory volume was associated with a significant reduction in mortality, emergency coronary artery bypass grafts and major complications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel